Thursday, April 9, 2020

Thursday, April 9, 2020

U.S. FOOD AND DRUG ADMINISTRATION: Sclerosol Intrapleural Aerosol


U.S. Food and Drug Administration recently issued the following announcement. 

Sclerosol Intrapleural Aerosol

Status: Currently in Shortage

»Date first posted: 02/16/2017

»Therapeutic Categories: Pulmonary/Allergy

Lymol Medical Corp. (Reverified 02/16/2017)

Company Contact Information: 781-935-0004

Presentation: Sclerosol 4 GM (NDC 63256-100-30)

Availability and Estimated Shortage Duration: To be determined

Shortage Reason (per FDASIA): Other

Original source can be found here.

Organizations in this Story

U.S. Food and Drug Administration

More News

FDA Reporter